1. Signaling Pathways
  2. GPCR/G Protein
    Neuronal Signaling
  3. Neurotensin Receptor

Neurotensin Receptor

The neuropeptide neurotensin (NT) exerts central actionsthat include hypothermia, analgesia, and a number of effects that involve the modulation of nigrostriatal and mesocortico-limbic dopaminergic pathways. The two neurotensin receptor subtypes known to date, NTR1 and NTR2, belong to the family of G-protein-coupled receptors with seven putative transmembrane domains (TM). The NTR1 has high affinity for neurotensin, whereas the NTR2 has lower affinity for the peptide and is selectively recognized by levocabastine, an anti-histamine H1 receptor antagonist. These receptors have widespread, though not identical, central and peripheral distributions and exhibit distinct ontogenic profiles.

It is notably reported that NTR1 activation results in significant antinociception but also causes marked hypotension and hypothermia. In sharp contrast, NTR2 has emerged as an important pain target because NTR2-selective analogues exhibit potent analgesic activity in both acute and chronic pain conditions in dose-dependent analgesic effects without inducing drop in blood pressure or body temperature.

Cat. No. Product Name Effect Purity Chemical Structure
  • HY-153687
    SORT-PGRN interaction inhibitor 2
    Inhibitor
    SORT-PGRN interaction inhibitor 2 is a SORT-PGRN inhibitor that can decreases SORT1 protein expression and increases extracellular PGRN secretion in mammalian cell lines. SORT-PGRN interaction inhibitor 2 can be used for neurological disease research.
    SORT-PGRN interaction inhibitor 2
  • HY-139668
    VGD071
    Inhibitor
    VGD071, a sortilin-targeting compound, is a promising candidate for future studies using mouse breast cancer models.
    VGD071
  • HY-182674
    VGD020
    Inhibitor
    VGD020 is a highly potent and selective Sec61 translocon inhibitor. VGD020 suppresses the expression of cell surface CD4 by inhibiting signal peptide-dependent co-translational ER translocation, interferes with the initiation of ER translocation of dengue virus polyprotein, and reduces the expression of Sortilin in breast cancer cells. VGD020 exhibits broad anti-flavivirus and anti-HIV activities. VGD020 can be used in research related to dengue virus infection, Zika virus infection, yellow fever virus infection, human immunodeficiency virus infection, and breast cancer.
    VGD020
  • HY-W574030
    Fmoc-DL-Leu-OH
    Agonist
    Fmoc-DL-Leu-OH acts as a partial agonist of the neurotensin NTS1 receptor (NTS1R) with an EC50 of 215.50 μM. Fmoc-DL-Leu-OH triggers intracellular calcium mobilization, and its activity is blocked by selective NTS1R antagonists. Fmoc-DL-Leu-OH can be used in the research of schizophrenia.
    Fmoc-DL-Leu-OH
  • HY-P3057
    [D-Trp11]-Neurotensin
    Modulator
    [D-Trp11]-Neurotensin, an analogue of Neurotensin (NT), is a selective antagonist of NT in perfused rat hearts but behaves as a full agonist in guinea pig atria and rat stomach strips. [D-Trp11]-Neurotensin can inhibit NT-induced hypotension.
    [D-Trp11]-Neurotensin
  • HY-P0251A
    Neurotensin(8-13) TFA
    Agonist
    Neurotensin (8-13) is an active fragment of Neurotensin. Neurotensin(8-13) TFA results in a decrease in cell-surface NT1 receptors (NTR1) density.
    Neurotensin(8-13) TFA
  • HY-RS09640
    Ntsr1 Rat Pre-designed siRNA Set A
    Inhibitor

    Ntsr1 Rat Pre-designed siRNA Set A contains three designed siRNAs for Ntsr1 gene (Rat), as well as a negative control, a positive control, and a FAM-labeled negative control.

    Ntsr1 Rat Pre-designed siRNA Set A
  • HY-P1257
    Xenin-8
    Xenin-8, a C-terminal octapeptide, is a biologically active fragment of Xenin. Xenin is a 25-amino acid peptide of the neurotensin/xenopsin family. Xenin-8 stimulates basal insulin secretion and potentiates the insulin response to glucose in a dose-dependent manner (EC50=0.16 nM).
    Xenin-8
  • HY-159876
    SORT1-IN-3
    Inhibitor
    SORT1-IN-3 (compound 5) is a blood-brain barrier permeable SORT1 inhibitor.
    SORT1-IN-3
  • HY-182551
    SR-12062
    Agonist
    SR-12062 is a Neurotensin receptor 1 (NTSR1) full agonist that modulates NTSR1 to trigger intracellular Ca2+ mobilization. SR-12062 can be used for the research of schizophrenia, parkinson’s disease, drug addiction.
    SR-12062
  • HY-159868
    SORT1-IN-1
    Inhibitor
    SORT1-IN-1 (compound 2) is a SORT1 inhibitor.
    SORT1-IN-1
  • HY-14551B
    (S)-Osanetant
    Antagonist 99.25%
    (S)-Osanetant is the S-enantiomer of Osanetant. Osanetant (SR142801) is a selective NK3 receptor antagonist. Osanetant produces anxiolytic- and antidepressant-like effects and is researched for schizophrenia.
    (S)-Osanetant
  • HY-159878
    SORT1-IN-5
    Inhibitor
    SORT1-IN-5 (compound 3) is a blood-brain barrier permeable SORT1 inhibitor. SORT1-IN-5 is an MSOH salt with limited oral bioavailability.
    SORT1-IN-5
  • HY-P2204
    PD-149163
    Agonist
    PD-149163 is an NTR-1 agonist. PD-149163 reverses intestinal damage through its anti-inflammatory, antioxidant, and cell proliferation promoting properties. PD-149163 has antipsychotic effects. PD-149163 is commonly used in research on mental illness and intestinal injury.
    PD-149163
  • HY-RS09642
    Ntsr2 Mouse Pre-designed siRNA Set A
    Inhibitor

    Ntsr2 Mouse Pre-designed siRNA Set A contains three designed siRNAs for Ntsr2 gene (Mouse), as well as a negative control, a positive control, and a FAM-labeled negative control.

    Ntsr2 Mouse Pre-designed siRNA Set A
  • HY-RS09643
    Ntsr2 Rat Pre-designed siRNA Set A
    Inhibitor

    Ntsr2 Rat Pre-designed siRNA Set A contains three designed siRNAs for Ntsr2 gene (Rat), as well as a negative control, a positive control, and a FAM-labeled negative control.

    Ntsr2 Rat Pre-designed siRNA Set A
  • HY-P0066
    Contulakin G
    Agonist
    Contulakin G is an O-glycosylated invertebrate neurotensin. Contulakin-G is a weaker agonist for the neurotensin receptor. Contulakin G is also a potent antinociceptive agent.
    Contulakin G
  • HY-149941
    hNTS1R agonist-1
    Agonist
    hNTS1R agonist-1 (Compound 10) is a BBB permeable hNTS1R full agonist (Ki: 6.9 nM) . hNTS1R agonist-1 increases motor function and memory in a mouse model of Parkinson's disease (PD). hNTS1R agonist-1 is a Neurotensin(8-13) analog and is a neuroprotective agent.
    hNTS1R agonist-1
  • HY-P10767
    MD01-67
    Activator
    MD01-67 is a selective macrocyclic compound targeting the neurotensin receptor type 2 (NTS2), with Ki of 2.9 nM. MD01-67 exhibits analgesic and tactile hypersensitivity reducing activity in rats acute/persistent/chronic inflammatory pain models.
    MD01-67
  • HY-RS09641
    NTSR2 Human Pre-designed siRNA Set A
    Inhibitor

    NTSR2 Human Pre-designed siRNA Set A contains three designed siRNAs for NTSR2 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

    NTSR2 Human Pre-designed siRNA Set A
Cat. No. Product Name / Synonyms Application Reactivity

Your Search Returned No Results.

Sorry. There is currently no product that acts on isoform together.

Please try each isoform separately.